- Home
- ADSE vs GRAL Comparison
ADSE vs GRAL Comparison
Compare ADSE & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- GRAL
- Stock Information
- Founded
- ADSE 1980
- GRAL 2016
- Country
- ADSE Ireland
- GRAL United States
- Employees
- ADSE N/A
- GRAL 1000
- Industry
- ADSE Industrial Specialties
- GRAL
- Sector
- ADSE Consumer Discretionary
- GRAL
- Exchange
- ADSE Nasdaq
- GRAL NYSE
- Market Cap
- ADSE 713.5M
- GRAL 1.6B
- IPO Year
- ADSE N/A
- GRAL N/A
- Fundamental
- Price
- ADSE $11.14
- GRAL $41.07
- Analyst Decision
- ADSE
- GRAL Buy
- Analyst Count
- ADSE 0
- GRAL 3
- Target Price
- ADSE N/A
- GRAL $31.50
- AVG Volume (30 Days)
- ADSE 86.0K
- GRAL 1.3M
- Earning Date
- ADSE 05-12-2025
- GRAL 08-12-2025
- Dividend Yield
- ADSE N/A
- GRAL N/A
- EPS Growth
- ADSE N/A
- GRAL N/A
- EPS
- ADSE N/A
- GRAL N/A
- Revenue
- ADSE $113,896,884.00
- GRAL $130,711,000.00
- Revenue This Year
- ADSE $219.58
- GRAL $19.52
- Revenue Next Year
- ADSE N/A
- GRAL $20.37
- P/E Ratio
- ADSE N/A
- GRAL N/A
- Revenue Growth
- ADSE 2.45
- GRAL 30.47
- 52 Week Low
- ADSE $9.00
- GRAL $12.33
- 52 Week High
- ADSE $16.35
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- ADSE 42.13
- GRAL N/A
- Support Level
- ADSE $11.00
- GRAL N/A
- Resistance Level
- ADSE $13.90
- GRAL N/A
- Average True Range (ATR)
- ADSE 0.93
- GRAL 0.00
- MACD
- ADSE -0.17
- GRAL 0.00
- Stochastic Oscillator
- ADSE 10.14
- GRAL 0.00
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.